Haptocorrin as marker of disease progression in fibrolamellar hepatocellular carcinoma

European Journal of Surgical Oncology

Volumn 37, Issue 1, 2011, Pages 72-79

  Lildballe, D L ^a   Nguyen, K Q T ^b,d   Poulsen, S S ^c   Nielsen, H O ^b   Nexo, E ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Fibrolamellar hepatocellular carcinoma; Haptocorrin; Vitamin B12

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; BILIRUBIN; BIOLOGICAL MARKER; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN; CYANOCOBALAMIN; CYANOCOBALAMIN BINDING PROTEIN; CYCLOPHOSPHAMIDE; DNA; HAPTOCORRIN; LACTATE DEHYDROGENASE; MESSENGER RNA; RNA; THALIDOMIDE;

ADOLESCENT; ARTICLE; CANCER GROWTH; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FIBROLAMELLAR HEPATOCELLULAR CARCINOMA; HALF LIFE TIME; HEMIHEPATECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HALF LIFE; TREATMENT DURATION; TUMOR BIOPSY; TUMOR CELL;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; MALE; TOMOGRAPHY, X-RAY COMPUTED; TRANSCOBALAMINS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650292475     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.11.001     Document Type: Article

References (32)

1. F. Stipa, S.S. Yoon, and K.H. Liau Outcome of patients with fibrolamellar hepatocellular carcinoma Cancer 106 6 2006 1331 1338
2. F.J. Paradinas, W.M. Melia, and M.L. Wilkinson High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma Br Med J (Clin Res Ed) 285 6345 1982 840 842
3. S. Waxman, C.K. Liu, C. Schreiber, and L. Helson The clinical and physiological implications of hepatoma b12-binding proteins Cancer Res 37 6 1977 1908 1914
4. K. Wheeler, J. Pritchard, W. Luck, and M. Rossiter Transcobalamin I as a "marker" for fibrolamellar hepatoma Med Pediatr Oncol 14 4 1986 227 229
5. H.G. Kwee Fibrolamellar hepatocellular carcinoma Am Fam Physician 40 2 1989 175 177
6. S.P. Kane, I.M. Murray-Lyon, and F.J. Paradinas Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma Gut 19 12 1978 1105 1109
7. E. Nexo, H. Olesen, K. Norredam, and M. Schwartz A rare case of megaloblastic anaemia caused by disturbances in the plasma cobalamin binding proteins in a patient with hepatocellular carcinoma Scand J Haematol 14 5 1975 320 327
8. D.L. Lildballe, T.F. Hardlei, L.H. Allen, and E. Nexo High concentrations of haptocorrin interfere with routine measurement of cobalamins in human serum and milk. A problem and its solution Clin Chem Lab Med 47 2 2009 182 187
9. C. Gottlieb, K.S. Lau, L.R. Wasserman, and V. Herbert Rapid charcoal assay for intrinsic factor (IF), gastric juice unsaturated B12 binding capacity, antibody to IF, and serum unsaturated B12 binding capacity Blood 25 1965 875 884
10. E. Nexo, A.L. Christensen, T.E. Petersen, and S.N. Fedosov Measurement of transcobalamin by ELISA Clin Chem 46 10 2000 1643 1649
11. A.L. Morkbak, J.F. Pedersen, and E. Nexo Glycosylation independent measurement of the cobalamin binding protein haptocorrin Clin Chim Acta 356 1-2 2005 184 190
12. A.L. Morkbak, S.S. Poulsen, and E. Nexo Haptocorrin in humans Clin Chem Lab Med 45 12 2007 1751 1759
13. B.O. Schlemmer, B.S. Sorensen, J. Overgaard, K.E. Olsen, L.M. Gjerdrum, and E. Nexo Quantitative PCR-new diagnostic tool for quantifying specific MRNA and DNA molecules: HER2/Neu DNA quantification with lightcycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization Scand J Clin Lab Invest 64 5 2004 511 522
14. K. Ejskjaer, B.S. Sorensen, S.S. Poulsen, O. Mogensen, A. Forman, and E. Nexo Expression of the epidermal growth factor system in human endometrium during the menstrual cycle Mol Hum Reprod 11 8 2005 543 551
15. A.A. Memon, B.S. Sorensen, P. Melgard, L. Fokdal, T. Thykjaer, and E. Nexo Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients Br J Cancer 91 12 2004 2034 2041
16. F. Meriggi, and E. Forni Surgical therapy of hepatic fibrolamellar carcinoma Ann Ital Chir 78 1 2007 53 58
17. O. Soreide, A. Czerniak, H. Bradpiece, S. Bloom, and L. Blumgart Characteristics of Fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature Am J Surg 151 4 1986 518 523
18. R. Carmel, and L. Eisenberg Serum vitamin B12 and transcobalamin abnormalities in patients with cancer Cancer 40 3 1977 1348 1353
19. R. Carmel The distribution of endogenous cobalamin among cobalamin-binding proteins in the blood in normal and abnormal states Am J Clin Nutr 41 4 1985 713 719
20. P. Gimsing, and E. Hippe Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast Scand J Haematol 21 3 1978 243 249
21. S. Waxman, and H.S. Gilbert A tumor-related vitamin B12 binding protein in adolescent hepatoma N Engl J Med 289 20 1973 1053 1056
22. V. Maniaci, B.R. Davidson, and K. Rolles Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy Eur J Surg Oncol 35 6 2009 617 621
23. F. Boisson, S. Fremont, and C. Migeon Human haptocorrin in hepatocellular carcinoma Cancer Detect Prev 23 2 1999 89 96
24. R.L. Burger, S. Waxman, H.S. Gilbert, C.S. Mehlman, and R.H. Allen Isolation and Characterization of a novel vitamin B12-binding protein associated with hepatocellular carcinoma J Clin Invest 56 5 1975 1262 1270
25. A.A. Ermens, L.T. Vlasveld, and J. Lindemans Significance of elevated cobalamin (vitamin B12) levels in blood Clin Biochem 36 8 2003 585 590
26. E. Nexo, H. Olesen, J.M. Christensen, J. Thomsen, and K. Kristiansen Characterization of a cobalamin-binding plasma protein from a patient with hepatoma Scand J Clin Lab Invest 35 7 1975 683 690
27. R.L. Burger, C.S. Mehlman, and R.H. Allen Human plasma R-type vitamin B12-binding proteins. I. Isolation and characterization of Transcobalamin I. Transcobalamin III. and the normal granulocyte vitamin B12-binding protein J Biol Chem 250 19 1975 7700 7706
28. R.L. Burger, R.J. Schneider, C.S. Mehlman, and R.H. Allen Human plasma R-type vitamin B12-binding proteins. II. The role of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein in the plasma transport of vitamin B12 J Biol Chem 250 19 1975 7707 7713
29. E. Nexo, and P. Gimsing Turnover in humans of iodine- and cobalamin-labeled transcobalamin I and of iodine-labeled albumin Scand J Clin Lab Invest 35 5 1975 391 398
30. P. Gimsing, and E. Nexo The metabolism in man of intravenously injected iodine-labelled trascobalamin I not saturated with cobalamin Scand J Clin Lab Invest 36 7 1976 669 672
31. R. Beedholm-Ebsen, W.K. van de, T. Hardlei, E. Nexo, P. Borst, and S.K. Moestrup Identification of multidrug resistance protein 1 (MRP1/ABCC1) as a molecular gate for cellular export of cobalamin Blood 2009
32. P. Gimsing, and E. Nexo The turnover of 57Co-labeled cyanocobalamin bound to cobalamin binding proteins in patients with chronic myelogenous leukemia J Lab Clin Med 123 2 1994 264 272